RGEN
Repligen Corp
Price:  
146.92 
USD
Volume:  
399,506.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RGEN EV/EBITDA

-88.1%
Upside

As of 2025-02-19, the EV/EBITDA ratio of Repligen Corp (RGEN) is -114.56. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RGEN's latest enterprise value is 7,969.57 mil USD. RGEN's TTM EBITDA according to its financial statements is -69.56 mil USD. Dividing these 2 quantities gives us the above RGEN EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 14.4x - 18.9x 16.5x
Forward P/E multiples 19.4x - 24.1x 21.7x
Fair Price (13.20) - 55.76 17.47
Upside -109.0% - -62.0% -88.1%
146.92 USD
Stock Price
17.47 USD
Fair Price

RGEN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-02-14 -114.56
2025-02-13 -113.96
2025-02-12 -113.60
2025-02-11 -116.63
2025-02-10 -120.15
2025-02-07 -121.92
2025-02-06 -126.60
2025-02-05 -126.65
2025-02-04 -125.12
2025-02-03 -125.00
2025-01-31 -130.10
2025-01-30 -131.16
2025-01-29 -132.67
2025-01-28 -136.57
2025-01-27 -131.55
2025-01-24 -129.84
2025-01-23 -131.46
2025-01-22 -130.61
2025-01-21 -131.48
2025-01-17 -125.51
2025-01-16 -127.40
2025-01-15 -122.92
2025-01-14 -122.32
2025-01-13 -123.84
2025-01-10 -120.96
2025-01-08 -120.83
2025-01-07 -119.86
2025-01-06 -120.30
2025-01-03 -116.96
2025-01-02 -111.45
2024-12-31 -112.16
2024-12-30 -112.06
2024-12-27 -113.45
2024-12-26 -113.65
2024-12-24 -114.59
2024-12-23 -113.54
2024-12-20 -112.58
2024-12-19 -114.26
2024-12-18 -114.90
2024-12-17 -123.60
2024-12-16 -125.84
2024-12-13 -122.21
2024-12-12 -121.87
2024-12-11 -121.27
2024-12-10 -118.61
2024-12-09 -120.85
2024-12-06 -116.40
2024-12-05 -110.81
2024-12-04 -116.31
2024-12-03 -115.84